Paper54923
A molecular concept of the properdin pathway.
Medicus RG and 3 others. Proc Natl Acad Sci U S A, 1976. Cited by 94 papers, by iCite.
Cite this record
ConductScience Library. A molecular concept of the properdin pathway. Papers, record 54923. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/54923
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics6
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Complement C3 | Major topic |
| Complement System Proteins | Major topic |
| Models, Biological | Major topic |
| Properdin | Major topic |
| Beta-Globulins | |
| Complement C5 |
Source PubMed
References18
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 4169693 | Properties of highly purified human properdin. | J Immunol | 1968 | https://conductscience.org/library/papers/4169693 | PubMed |
| 2 | 4111773 | C3 proactivator convertase and its mode of action. | J Exp Med | 1972 | https://conductscience.org/library/papers/4111773 | PubMed |
| 3 | 4207623 | A serum factor in chronic hypocomplementemic hephritis distinct from immunoglobulins and activating the alternate pathway of complement. | J Exp Med | 1974 | https://conductscience.org/library/papers/4207623 | PubMed |
| 4 | 4632688 | The alternate pathway of complement activation. The role of C3 and its inactivator (KAF). | Immunology | 1973 | https://conductscience.org/library/papers/4632688 | PubMed |
| 5 | 4734384 | Alternate complement pathway: factors involved in cobra venom factor (CoVF) activation of the third component of complement (C3). | J Immunol | 1973 | https://conductscience.org/library/papers/4734384 | PubMed |
| 6 | 47885 | The membrane attack mechanism of complement. Isolation and subunit composition of the C5b-9 complex. | J Exp Med | 1975 | https://conductscience.org/library/papers/47885 | PubMed |
| 7 | 4808709 | The role of properdin in the alternate pathway of complement activation. | J Exp Med | 1974 | https://conductscience.org/library/papers/4808709 | PubMed |
| 8 | 5645214 | The demonstration in human serum of "conglutinogen-activating factor" and its effect on the third component of complement. | J Immunol | 1968 | https://conductscience.org/library/papers/5645214 | PubMed |
| 9 | 6019133 | Formation and functional significance of a molecular complex derived from the second and the fourth component of human complement. | J Exp Med | 1967 | https://conductscience.org/library/papers/6019133 | PubMed |
| 10 | 1056006 | Third component of complement (C3): structural properties in relation to functions. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1056006 | PubMed |
| 11 | 1059108 | Properdin: initiation of alternative complement pathway. | Proc Natl Acad Sci U S A | 1975 | https://conductscience.org/library/papers/1059108 | PubMed |
| 12 | 1092789 | Immunologic injury of cultured cells infected with measles virus. I. role of IfG antibody and the alternative complement pathway. | J Exp Med | 1975 | https://conductscience.org/library/papers/1092789 | PubMed |
| 13 | 1159084 | Complete absence of the third component of complement in man. | J Clin Invest | 1975 | https://conductscience.org/library/papers/1159084 | PubMed |
| 14 | 1165475 | Properdin- and nephritic factor-dependent C3 convertases: requirement of native C3 for enzyme formation and the function of bound C3b as properdin receptor. | J Exp Med | 1975 | https://conductscience.org/library/papers/1165475 | PubMed |
| 15 | 1185108 | Properdin: binding to C3b and stabilization of the C3b-dependent C3 convertase. | J Exp Med | 1975 | https://conductscience.org/library/papers/1185108 | PubMed |
| 16 | 126576 | Formation and composition of the C3 activating enzyme complex of the properdin system. Sequential assembly of its components on solid-phase trypsin-agarose. | Z Immunitatsforsch Exp Klin Immunol | 1975 | https://conductscience.org/library/papers/126576 | PubMed |
| 18 | 4105810 | The C3-activator system: an alternate pathway of complement activation. | J Exp Med | 1971 | https://conductscience.org/library/papers/4105810 | PubMed |
| 19 | 4202731 | Formation of a hemolytically active cellular intermediate by the interaction between properdin factors B and D and the activated third component of complement. | J Exp Med | 1973 | https://conductscience.org/library/papers/4202731 | PubMed |
Cited by31
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 94 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 35031611 | Structure and function of a family of tick-derived complement inhibitors targeting properdin. | Nat Commun | 2022 | https://conductscience.org/library/papers/35031611 | PubMed |
| 30141176 | The role of properdin in complement-mediated renal diseases: a new player in complement-inhibiting therapy? | Pediatr Nephrol | 2019 | https://conductscience.org/library/papers/30141176 | PubMed |
| 29167939 | The properdin pathway: an "alternative activation pathway" or a "critical amplification loop" for C3 and C5 activation? | Semin Immunopathol | 2018 | https://conductscience.org/library/papers/29167939 | PubMed |
| 27018802 | Structural basis for therapeutic inhibition of complement C5. | Nat Struct Mol Biol | 2016 | https://conductscience.org/library/papers/27018802 | PubMed |
| 26082779 | Complement System Part I - Molecular Mechanisms of Activation and Regulation. | Front Immunol | 2015 | https://conductscience.org/library/papers/26082779 | PubMed |
| 20382442 | Native polymeric forms of properdin selectively bind to targets and promote activation of the alternative pathway of complement. | Immunobiology | 2010 | https://conductscience.org/library/papers/20382442 | PubMed |
| 20304920 | Convertase inhibitory properties of Staphylococcal extracellular complement-binding protein. | J Biol Chem | 2010 | https://conductscience.org/library/papers/20304920 | PubMed |
| 6904360 | Interactions of chrysotile asbestos fibres with the complement system. | Immunology | 1980 | https://conductscience.org/library/papers/6904360 | PubMed |
| 6903192 | Relation of putative thioester bond in C3 to activation of the alternative pathway and the binding of C3b to biological targets of complement. | J Exp Med | 1980 | https://conductscience.org/library/papers/6903192 | PubMed |
| 6316456 | Synthesis of lipids or lipid-containing macromolecules in tumor cells. Relevance to host defense. | Surv Immunol Res | 1983 | https://conductscience.org/library/papers/6316456 | PubMed |
| 6238433 | The alternative pathway of complement. | Springer Semin Immunopathol | 1984 | https://conductscience.org/library/papers/6238433 | PubMed |
| 3307764 | Resolution and analysis of 'native' and 'activated' properdin. | Biochem J | 1987 | https://conductscience.org/library/papers/3307764 | PubMed |
| 1067618 | Control of the amplification convertase of complement by the plasma protein beta1H. | Proc Natl Acad Sci U S A | 1976 | https://conductscience.org/library/papers/1067618 | PubMed |
| 879873 | Changes in humoral components of host defense following burn trauma. | Ann Surg | 1977 | https://conductscience.org/library/papers/879873 | PubMed |
| 830792 | Requirements for the solubilization of immune aggregates by complement: assembly of a factor B-dependent C3-convertase on the immune complexes. | J Exp Med | 1977 | https://conductscience.org/library/papers/830792 | PubMed |
| 721136 | Solid phase activation of alternative pathway of complement by beta-1,3-glucans and its possible role for tumour regressing activity. | Immunology | 1978 | https://conductscience.org/library/papers/721136 | PubMed |
| 666383 | Host defense against opportunist microorganisms following trauma. I. Studies to determine the association between changes in humoral components of host defense and septicemia in burned patients. | Ann Surg | 1978 | https://conductscience.org/library/papers/666383 | PubMed |
| 666370 | Host defense against opportunist microorganisms following trauma. II. Changes in complement and immunoglobulins in patients with abdominal trauma and in septic patients without trauma. | Ann Surg | 1978 | https://conductscience.org/library/papers/666370 | PubMed |
| 627406 | Binding of activated properdin to untreated erythrocytes: a new function of activated properdin. | Immunology | 1978 | https://conductscience.org/library/papers/627406 | PubMed |
| 590998 | Insoluble polyanions as activators of both pathways of complement. | Immunology | 1977 | https://conductscience.org/library/papers/590998 | PubMed |
Genes5
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| C3 | 718 | PubTator's text mining | https://conductscience.org/library/genes/718 | NCBI Gene |
| C5 | 727 | PubTator's text mining | https://conductscience.org/library/genes/727 | NCBI Gene |
| CFI | 3426 | PubTator's text mining | https://conductscience.org/library/genes/3426 | NCBI Gene |
| CFP | 5199 | PubTator's text mining | https://conductscience.org/library/genes/5199 | NCBI Gene |
| ERVK-3 | 100862689 | PubTator's text mining | https://conductscience.org/library/genes/100862689 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/54923
GET https://conductscience.org/api/papers/v1/54923/cited_by?page=2